A Novatis’s campaign has reached nearly 1.6 million people in 37 provinces and cities, providing them with information, examination and early treatment for chronic conditions such as hypertension and diabetes.
Novartis Vietnam collaborated with Vietnam Cardiovascular Foundation and the southern Long An Province to celebrate the 10th anniversary of the “Healthy Family” program on Nov. 11, marking a decade of accompanying Vietnamese people in improving health quality.
The event was attended by representatives of the Center for Disease Control (CDC) in Long An, Yen Bai, Bac Ninh, Phu Yen, Thai Nguyen, Dak Lak, Nghe An, Quang Binh, Soc Trang, Tra Vinh provinces.
To create opportunities for more people to have easy access to medical services, since 2012, Novartis has implemented “Healthy Family” program, with the companionship of Vietnam Cardiovascular Foundation and local health departments. The program cooperates with health centers to conduct screening sessions and disseminate information about hypertension and diabetes for people over 40 years old in districts across the country, with priority given to remote areas.
By 2021, “Healthy Family” program has reached nearly 1.6 million people in 37 provinces and cities such as Lang Son, Bac Giang, Yen Bai, Bac Ninh, Phu Yen, Thai Nguyen, Khanh Hoa, Dak Lak, Nghe An, Quang Binh, Soc Trang, Tra Vinh, Hau Giang, Dong Thap …
Each year, the program reached approximately 200,000 people in 15 localities, with an annual budget of up to VND6-7 billion. Through the program, people could access basic knowledge about diseases and be screened for diabetes and hypertension.
About 15-20% of participants were detected and diagnosed with signs of high blood pressure, 7-8% had high blood sugar and continued to be monitored at health stations.
In addition, the program also strengthened the consulting capacity and expertise of local health workers, thereby improving the quality of community health care.
“Overcoming geographical constraints, we implement “Healthy Family” program with the aim of helping people access good health services at an affordable cost. The 10-year journey has confirmed the sustainability and maintainability of the program as well as Novartis’ commitment to the health of Vietnamese people,” Carolyne Hall Director, Global Health Access Solution Center of Excellence, Novartis global, said.
The Novartis representative also expressed her desire to expand the program scale year after year, with the first step of expanding to one more province each year, and at the same time, supplement interventions related to other chronic diseases such as heart failure and breast cancer.
Grassroots medical care in remote areas
Among the common chronic diseases, non-communicable diseases (NCDs) are now four times the cause of death than infectious diseases. Not only in developed countries but also in developing ones, the risk factors for NCDs – such as sedentary lifestyles and unhealthy diets – are being multiplied.
Hypertension and diabetes are two common non-communicable diseases and require regular and long-term treatment. According to statistics from the Ministry of Health, 60% of people with high blood pressure in Vietnam have not been detected and over 80% have not been treated. In recent years, this pathology is getting younger. Hypertension is considered a silent killer and is the leading cause of death.
Diabetes is increasing steadily in recent years globally. According to statistics from the International Diabetes Federation, in 2017, approximately 425 milion people had dibetes in the world. In Vietnam, about 3.5 milion peoples had been living with this disease.
However, access to primary care and resources are scarce in some remote localities. In provinces such as Bac Giang, Yen Bai, Lang Son, and Dak Lak… health stations are far away from where they live, traffic is obstructed, human resources for medical staff, doctors and medicines are still limited.
Therefore, many people have missed the opportunity to be screened early, and missed the golden time for treatment. On the other hand, some refuse to get medical examination and treatment locally, leading to overcrowding at central hospitals. This is also part of the reason for the widespread burden on the medical care in Vietnam, and at the same time hinders the long-term improvement of Vietnamese people’s health.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, Novartis uses innovative science and digital technologies to transform treatments in areas of great medical need.
Novartis products reach nearly 800 million people globally. About 11